PSP, CBD and MSA Research

CurePSP is devoted to better understanding the causes of progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA), accelerating the development of diagnostic tools and help advance treatments that may prevent, slow, stop or even reverse disease progression.

CurePSP supports and accelerates research by:

• Funding PSP and CBD research projects.
• Supporting biomarker development through the Biomarker Accelerator Program.
• Collaborating with our Centers of Care network to publish findings on PSP, CBD and MSA research, which can be found on this page.
• Connecting you to resources and research opportunities that help scientists further understand these diseases.
• Supporting researchers working on these diseases through grant funding and scientific conferences. See our For Researchers Page here.

CurePSP resources on research:

• The Collective Mind: Episode 6: Investigating Blood-Based Biomarkers
• Clinical Trials in Action - Session from CurePSP’s 2025 Care Conference
• State of the Science - Session from CurePSP's 2026 Spring Community Weekend
• What Causes Rare Neurodegenerative Diseases? Exploring the Genetics of PSP, CBD and MSA? - Blog post
• A Guide to Clinical Trials: Understanding How New Treatments Are Developed - Blog post

Interested in participating in research? Learn about current and future PSP, CBD and MSA research opportunities here.